Evidence map›Paper›PMID 22440150›Full record

ArticleInternational journal of pharmaceutics2012

Improving matrix metalloproteinase-2 specific response of a hydrogel system using electrophoresis.

Yu Zhang, Richard A Gemeinhart

Open access · greenAbstract read
In one paragraph

Article in International journal of pharmaceutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Review
  2. Review
  3. Article
  4. Proteolytically activated anti-bacterial hydrogel microspheres.Journal of controlled release : official journal of the Controlled Release Society · 2013
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yu ZhangDepartment of Biopharmaceutical Sciences, University of Illinois, Chicago, IL 60612-7231, USA.
Richard A Gemeinhart
University of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · US

Funding

Understanding and Preventing Tumor Disperal with Hydrogel TherapeuticsR01NS055095 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GEMEINHART, RICHARD A · 2007 to 2011
$1.7M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR015482 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BAUMAN, JERRY L · 2000 to 2000
$909k
Targeted Drug Delivery via Microparticle-Drug ConjugatesR03EY014357 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GEMEINHART, RICHARD A · 2003 to 2005
$454k
NCRR NIH HHS C06 RR015482NCRR NIH HHS C06 RR15482NEI NIH HHS R03 EY014357NINDS NIH HHS R01 NS055095
6 · The paper itself

Abstract

Matrix metalloproteinases (MMPs) overexpression plays a critical role in cancer invasion and metastasis. We utilized this key feature of tumor microenvironment to develop a disease-stimuli triggered drug delivery system. Poly(acrylic acid) hydrogels were synthesized by UV polymerization and pendant MMP-2 sensitive peptides (Gly-Pro-Leu-Gly-Val-Arg-Gly-Lys) conjugated throughout using EDC/sulfo-NHS chemistry. There were significantly more peptides released in the presence of MMP-2 compared with the control groups. The released peptide fragments were analyzed by HPLC and MALDI-MS and confirmed to be the expected fragments. In order to avoid nonspecific release of nonconjugated (i.e. unreacted) peptides, a novel method of electrophoretic washing was developed disrupting the strong electrostatic interactions between the peptides and the pendant groups of the hydrogel. After electrophoresis, the nonspecific peptide release in the absence of MMP-2 was minimized. This newly developed purification system significantly improved the control of release to be in response of the magnitude of the stimuli, i.e. MMP. Specifically, peptides were released proportionally to the concentration of MMP-2 present. Now that many of the design parameters have been examined, anticancer drugs will be conjugated to the MMP sensitive peptide linkers with the goal of implantation in a tumor void releasing anticancer reagent in response to elevated level of MMPs.

Indexed as

Drug Delivery SystemsAcrylic ResinsAntineoplastic AgentsChromatography, High Pressure LiquidDrug DesignElectrophoresisHumansHydrogelsMatrix Metalloproteinase 2PeptidesPolymerizationSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStatic ElectricityTumor MicroenvironmentUltraviolet RaysAcrylic ResinsAntineoplastic Agentscarbopol 940HydrogelsMatrix Metalloproteinase 2Peptides

Identifiers

PMID22440150
PMCPMC3327771
OpenAlexW2061697460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.